Long-term regular plasmapheresis as a maintenance treatment for chronic inflammatory demyelinating polyneuropathy

Journal of the Peripheral Nervous System

Volumn 15, Issue 2, 2010, Pages 147-149

  Isose, Sagiri ^a   Mori, Masahiro ^a   Misawa, Sonoko ^a   Shibuya, Kazumoto ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLOBULIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; BLOOD FILTER; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYPOALBUMINEMIA; JAPAN; LETTER; MAINTENANCE THERAPY; MALE; NERVE CONDUCTION; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; HUMANS; IMMUNOTHERAPY; LONG-TERM CARE; MALE; MIDDLE AGED; PLASMA EXCHANGE; PLASMAPHERESIS; POLYRADICULONEUROPATHY;

EID: 77954285092     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2010.00263.x     Document Type: Letter

References (11)

1. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV (1975). Chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc 50 : 621 637.
2. Dyck PJ, Litchy WJ, Kratz KM, Suarez GA, Low PA, Pineda AA, Windebank AJ, Karnes JL, O'Brien PC (1994). A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36 : 838 845.
3. Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN (2009). Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. In: The Cochrane Library, Issue 1. John Wiley & Sons, Ltd.
4. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978). Controlled trial of prednisolone in acute polyneuropathy. Lancet 2 : 750 753.
5. Hughes RA (2009). Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Expert Rev Neurother 9 : 789 795.
6. Joint Task Force of the EFNS and the PNS (2005). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10 : 220 228.
7. Kuwabara S, Misawa S, Mori M, Tamura N, Kubota M, Hattori T (2006). Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 77 : 66 70.
8. Mehndiratta MM, Hughes RAC (2002). Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. In: The Cochrane Library, Issue 1. John Wiley & Sons, Ltd.
9. Mehndiratta MM, Hughes RAC, Agarwal P (2004). Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. In: The Cochrane Library, Issue 3. John Wiley & Sons, Ltd.
10. Nagamatsu M, Terao S, Misu K, Li M, Hattori N, Ichimura M, Sakai M, Yamamoto H, Watanabe H, Riku S, Ikeda E, Hata J, Oda M, Satake M, Nakamura N, Matsuya S, Hashizume Y, Sobue G (1999). Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 66 : 727 733.
11. RMC Trial Group (2009). Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 8 : 158 164.